SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models
Pharmacology
[키워드] ACE-2
acute respiratory syndrome
Antiviral
blood vessel organoid
Calu-3
cause
cell line
cells
clinical sample
coronavirus
COVID-19
develop
drug design
Drug discovery
epithelial cell
epithelial cells
experimental model
experimental models
expression
H1299
HEK-293
human Angiotensin-converting enzyme
human lung
inefficient
Infection
intestinal epithelial cells
Intestinal Organoids
investigated
Laboratory
lung organoids
Model
molecular
molecular target
Molecular targets
morbidity and mortality
mouse model
Novel coronavirus
outbreak
outcomes
pandemic
Pathogenesis
potential molecular
Protein
recent
receptor
Research
researcher
SARS-CoV-2
SARS-CoV-2 biology
SARS-COV-2 infection
sequencing data
spike
target
targets
the SARS-CoV-2
therapeutic
transgenic
Treatment outcome
Vero cells
viral genome
viral life cycle
viral pathogen
viral pathogenesis
Viral protein
viral titer
X-ray
[DOI] 10.3389/fphar.2021.638334 PMC 바로가기 [Article Type] Pharmacology
[DOI] 10.3389/fphar.2021.638334 PMC 바로가기 [Article Type] Pharmacology